Weight Loss Drugs: Clinical Update on GLP-1 & GIP Receptor Agonists

Learning Objectives
Identify GLP-1 and GIP receptor agonist medications, their effectiveness, and safety in management of obesity.
Outline three established alternatives to hormone mimetics.
Identify three contraindications and FDA warnings for GLP-1 and GIP receptor agonists.
Describe how the information in this course can be utilized to improve patient care and patient outcomes in the firelds of nursing, pharmacy, dietetics, dentistry, mental health, long-term care, physical and occupational therapy, and other healthcare professions.
Course Offering: Seminar, Workshop, or Webinar - On-Demand (previously recorded)
Domain Focus: Quality and Outcomes Evaluation and Measurements
Start Date:
End Date:
CE Credits: 3.00
Fee: $74.00
Learn More